| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/03/1992 | EP0488061A2 The MAC-1 binding site of ICAM-1 |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
| 06/03/1992 | EP0487617A1 Synthetic peptides that enhance cell binding. |
| 06/03/1992 | EP0487610A1 Prohormone cleavage site blocking antibody |
| 06/03/1992 | EP0487525A1 Tuftsin analogs |
| 06/02/1992 | US5118796 Using cationic exchange resin |
| 06/02/1992 | US5118791 Biologically active polypeptides based on transforming growth factor-β |
| 06/02/1992 | US5118669 Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators |
| 06/02/1992 | US5118618 Dimethylglycine enhancement of antibody production |
| 06/02/1992 | US5118611 Adenocarcinoma antigen binding methods and reagents |
| 06/02/1992 | US5118610 Techniques for detecting insect contamination of foodstuffs |
| 06/02/1992 | US5118609 Carrier fleece for use as a reagent carrier from which reagents can be dissolved in immunological analysis |
| 06/02/1992 | US5118606 Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products |
| 06/02/1992 | CA1302319C Method of preventing, controlling or reducing adiposity |
| 05/31/1992 | WO1992010760A1 Methods for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | WO1992009631A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2097426A1 Method for the diagnosis of chronic lower back and cervical pain |
| 05/31/1992 | CA2097309A1 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor |
| 05/31/1992 | CA2056261A1 Antibody reactive to hamster immunoglobulins |
| 05/30/1992 | CA2056646A1 Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents |
| 05/29/1992 | WO1992009294A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | WO1992008983A1 Hiv marker/aids vaccine |
| 05/29/1992 | WO1992008982A1 Characterization of platelet aggregation disorders |
| 05/29/1992 | WO1992008981A1 Therapeutic and diagnostic methods using total leukocyte surface antigens |
| 05/29/1992 | WO1992008980A1 Therapeutic and diagnostic methods using cell-free cd35 |
| 05/29/1992 | WO1992008807A1 Preparation of nucleic acid samples |
| 05/29/1992 | WO1992008802A1 Bispecific antibodies, method of production, and uses thereof |
| 05/29/1992 | WO1992008790A1 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
| 05/29/1992 | WO1992008785A1 Diagnosis and treatment of multiple sclerosis |
| 05/29/1992 | WO1992008740A2 Receptor recognition factor and methods of use thereof |
| 05/29/1992 | WO1992008739A1 Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation |
| 05/29/1992 | WO1992008738A1 Monoclonal antibodies to hepatitis c virus and method for using same |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008491A1 Conjugates of anti-idiotype antibodies and carriers and their use in epitope-directed immunization |
| 05/29/1992 | WO1992008489A1 Treatment for inflammatory bowel disease |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008483A1 CONTROLLING β-AMYLOID RELATED NEURONAL DEGENERATION BY ANTAGONIZING NGF-EFFECTED NEURONAL ACTIVITY |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008474A2 Treatment of lung diseases |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992008471A1 Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies |
| 05/29/1992 | WO1992006199A3 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095626A1 Therapeutic and diagnostic methods using total leukocyte surface antigens |
| 05/29/1992 | CA2074476A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | CA2073511A1 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
| 05/27/1992 | EP0487298A2 Human gamma interferon antagonist/agonist screen |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | DE4037196A1 Verfahren zur reaktivierung von denaturiertem protein A process for the reactivation of denatured protein |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116952 Protein active in humoral hypercalcemia of malignancy-pthrp |
| 05/26/1992 | US5116948 Preparations of islet amyloid polypeptide (iapp) and antibodies to iapp |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | CA1301685C Phospholipid conjugates and their preparation |
| 05/26/1992 | CA1301647C Latex for immobilization of physiologically active substance and latexreagent using the latex |
| 05/23/1992 | WO1992009622A1 Process for reactivating denatured protein |
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0485749A2 Chemical modification of antibodies for creating of immunoconjugates |
| 05/20/1992 | EP0485525A1 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin. |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485430A1 Methods and compositions for ameliorating the symptoms of sepsis |
| 05/20/1992 | EP0485380A1 Immunological use of microwaves |
| 05/20/1992 | EP0476007A4 Catalytic antibodies |
| 05/20/1992 | EP0258404B1 Method of detecting antibody against htlv-iii |
| 05/20/1992 | EP0216864B1 Detection of activated platelets with antibodies to cell surface antigens |
| 05/20/1992 | EP0209539B1 Homogeneous erythropoietin |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/19/1992 | US5115101 Removal of protein A from antibody preparations |
| 05/19/1992 | US5115096 Amphiregulin: a bifunctional growth modulating glycoprotein |
| 05/19/1992 | US5114943 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 05/19/1992 | US5114863 Immunosorbant assay for α-1-antitrypsin, kit employing said assay, monoclonal antibody to α-1-antitrypsin, and hybridoma for producing said monoclonal antibody |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114712 Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection |
| 05/19/1992 | US5114710 M-csf as a therapeutic agent for thrombocytopenia |
| 05/19/1992 | US5114555 Separation of proteins with membranes in a multicompartment apparatus |
| 05/19/1992 | CA1301095C Human che type proteins and their production |
| 05/16/1992 | CA2048078A1 Chemical modification of antibodies for creation of immunoconjugates |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/14/1992 | WO1992008485A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007951A1 Quantitation of aldehyde-containing lesions in nucleic acids |
| 05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
| 05/14/1992 | WO1992007939A2 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides |
| 05/14/1992 | WO1992007584A1 Pharmaceutical preparation for the treatment of prolonged coagulation time |
| 05/14/1992 | WO1992007583A1 ANTI-UBIQUITIN IgG IN THE TREATMENT OF SYSTEMIC AMYLOIDOSIS |
| 05/14/1992 | WO1992007574A1 Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells |
| 05/14/1992 | WO1992007560A1 Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein |
| 05/14/1992 | WO1992004014A3 Regulation of neoplastic cell proliferation via a novel 5ht1a receptor |